Moderna forecasts $18bn in sales of Covid vaccine this year

Better than expected revenues will push US firm founded in 2010 into profit for first timeCoronavirus – latest updatesSee all our coronavirus coverageModerna expects to rake in $18.4bn (£13bn) of sales from its coronavirus vaccine this year, marking a huge turnaround in the fortunes of the US biotech firm.The expected revenue is far higher than the $11.2bn predicted by analysts, and exceeds the $15bn in sales that its US rival Pfizer expects for the Covid-19 vaccine that it developed with Germany’s BioNTech. Continue reading... https://www.theguardian.com/business/2021/feb/25/moderna-forecasts-18bn-in-sales-of-covid-vaccine-this-year #pharmaceuticals_industry #vaccines_and_immunisation #us_news #coronavirus #business #world_news